blog

Patient and Site Engagement in the Age of Integration

By BBK on Thu, Jun 22, 2017 | 3 min read

At this stage in the evolution of mHealth, how do we make it easier for sites and patients to stay engaged with a clinical trial? In this interview, BBK Worldwide’s Erica Mercado provides her insights on mHealth user experience optimization, adaptive engagement strategies, and mHealth’s integrated future.

Topics: Patient Engagement, clinical research, clinical trials

BBK to Present at DIA 2017

By BBK on Tue, May 23, 2017 | 2 min read

It’s that time of the year again – we are getting ready for DIA 2017 53rd Annual Meeting, which starts June 18th in Chicago. With over 7,000 life sciences professionals from across all disciplines expected to attend, we look forward to engaging in insightful and inspiring discussions with leading innovators from the healthcare and clinical research industries.

Topics: DIA, DIA 2017

The Patients to Find the Cure

By Joan F. Bachenheimer on Tue, May 16, 2017 | 5 min read

BBK Worldwide has coupled its reputation with the singular idea that placing patient and caregiver needs as the first priority for clinical research is a win-win for all involved. For more than twenty years, BBK has promoted the company tagline, “The Patients to Find the Cure.” Having moved our collected perspectives from the days where BBK was criticized for referring to “subjects” as “patients,” the current research environment reveres “patient centricity” as the industry mantra. So, what’s next? A new concern shrouds our efforts. The notion that technological solutions are at the root of patient-centric care, in fact, may defeat the very goal the industry wishes to accomplish.

Topics: Patient Centricity, clinical research

Advocating for Innovative Clinical Trial Recruitment Tactics

By Sarah Mandracchia on Fri, Apr 28, 2017 | 2 min read

Digital, mobile, programmatic. These terms have become buzzwords in our industry when discussing new and emerging trends in patient recruitment support. However, for me, the most interesting part of these concepts is not the way in which programming display ad buys work, or the mobile trends we are seeing with users in different age groups. When you consider that that these advertising vehicles have been in use for almost a decade, what’s most interesting to me is that the healthcare industry is just starting to adopt these as viable tactics for patient recruitment. 

Topics: advertising, clinical trials, Media

A Caregiver's Perspective on Rare Disease Clinical Trials

By Juli Greenwood on Thu, Apr 27, 2017 | 4 min read

Supporting rare disease research is a big part of our work here at BBK and rare disease recruitment is an expertise that our sponsors and CRO customers have come to expect from us.

While progress has been made to improve the lives of patients with rare disorders, there is much that still needs to be done to reach patients, further research, find new treatments and improve outcomes. Our most recent eBook, “Rare Disease Research. What’s Next?” is a collection of insights from a variety of rare disease stakeholders, including Roberta Carson, Founder and President of Zaggo, Inc. – a national nonprofit devoted to helping patients and families be more engaged members of their medical teams.

Topics: Most Viewed

Getting Patients to “See” Your Clinical Trial Advertising

By Justin Jones on Tue, Apr 25, 2017 | 3 min read

Name something that happens to you five times every waking minute. Give up? It’s advertisements. The average person is exposed to approximately five ad messages every minute, for a total of about 3000 to 5000 advertisements a day. From TV and radio commercials to surfing the web to walking around your local grocery store, the flood of advertisements trying to grab your attention has never been greater. So here are two questions I want you to consider: how many of those ads do you remember and did they motivate you to take action? 

Topics: Patient Recruitment, advertising, clinical trials

Empowering Patients with Innovative Tech & Strategies

By BBK on Fri, Mar 31, 2017 | 2 min read

Medication non-compliance is an epidemic that impacts patients, sponsors and the healthcare industry at large, costing the U.S. healthcare system around 300 billion dollars a year. According to a PM360 article that highlights medication compliance in diabetes patient populations, non-adherent patients have inpatient healthcare costs that are 41% higher than those of adherent patients. 

Topics: Patient Retention, mHealth, clinical research, Patient Travel

Innovative & Traditional Outreach for Clinical Research

By Erica Mercado on Wed, Mar 29, 2017 | 3 min read

The clinical research industry is unique among other industries for many reasons. Yet in the bigger picture, the way we interact with information has evolved, more or less, in step with the rest of the world. I can see parallels between changes in my own life and how clinical trials, and patient recruitment and engagement, have changed over the years.

Topics: mHealth, clinical research, clinical trials

Tips from March Madness: Promoting Clinical Trial Product Awareness

By Michael Johnson on Thu, Mar 23, 2017 | 3 min read

It’s the greatest time of the year, well at least in my opinion. It’s March Madness. For those of you who don’t know, every year in March the NCAA basketball tournament captures the eye of the sporting world, consisting of brackets, upsets, buzzer beaters, and heartbreak.

Where am I going with this? As I sit in my office, I think about some of the biggest issues that face the clinical trial industry regarding the adoption and implementation of new products.

Topics: clinical research, clinical trials

New eBook: Rare Disease Research. What’s Next?

By BBK on Thu, Feb 23, 2017 | 2 min read

Nearly a year ago, we released our first guide on rare disease clinical research. In it, we were looking to address some important questions facing the people who are committed to improving the lives of patients with rare disorders. While much progress has been made, it is critical that those of us in the health care and life sciences industry remain keenly aware of all that’s being done to further research and improve outcomes. In our latest eBook, “Focus 5: Rare Disease Research. What’s Next?” we reached out to industry experts for their insights on this evolving clinical research landscape.

Topics: Patient Recruitment, Patient Engagement, Rare Disease, clinical research

 
Subscribe To Our Blog